EAACI Congress 2024
BackSAT1-6 - BioCryst – Reimagining hereditary angioedema (HAE) care – is it time to define the new ‘normal’ for patients with HAE?
Objectives
- This promotional symposium is organised and funded by BioCryst® Pharmaceuticals and is intended for healthcare professionals only.
- Date of preparation: April 2024 | EU.HAE.00019